Related references
Note: Only part of the references are listed.mTOR inhibitors and renal allograft: Yin and Yang
Gianluigi Zaza et al.
JOURNAL OF NEPHROLOGY (2014)
Ischaemia-reperfusion injury: a major protagonist in kidney transplantation
Claudio Ponticelli
NEPHROLOGY DIALYSIS TRANSPLANTATION (2014)
Sulodexide and glycosaminoglycans in the progression of renal disease
Valentina Masola et al.
NEPHROLOGY DIALYSIS TRANSPLANTATION (2014)
Systemic and Nonrenal Adverse Effects Occurring in Renal Transplant Patients Treated with mTOR Inhibitors
Gianluigi Zaza et al.
CLINICAL & DEVELOPMENTAL IMMUNOLOGY (2013)
The need to reduce cold ischemia time in kidney transplantation
J. Adam van der Vliet et al.
CURRENT OPINION IN ORGAN TRANSPLANTATION (2013)
Adverse events associated with mTOR inhibitors
Nicolas Pallet et al.
EXPERT OPINION ON DRUG SAFETY (2013)
Everolimus-induced epithelial to mesenchymal transition in immortalized human renal proximal tubular epithelial cells: key role of heparanase
Valentina Masola et al.
JOURNAL OF TRANSLATIONAL MEDICINE (2013)
The role of EMT in renal fibrosis
Rosemarie M. Carew et al.
CELL AND TISSUE RESEARCH (2012)
The PI3K/AKT/mTOR Pathway as a Therapeutic Target in Endometrial Cancer
Brian M. Slomovitz et al.
CLINICAL CANCER RESEARCH (2012)
Protective effect of heparin in the end organ ischemia/reperfusion injury of the lungs and heart
Hikmet Selcuk Gedik et al.
JOURNAL OF CARDIOTHORACIC SURGERY (2012)
A new mechanism of action of sulodexide in diabetic nephropathy: inhibits heparanase-1 and prevents FGF-2-induced renal epithelial-mesenchymal transition
Valentina Masola et al.
JOURNAL OF TRANSLATIONAL MEDICINE (2012)
New strategies to optimize kidney recovery and preservation in transplantation
Delphine Bon et al.
NATURE REVIEWS NEPHROLOGY (2012)
Machine Perfusion or Cold Storage in Deceased-Donor Kidney Transplantation
Cyril Moers et al.
NEW ENGLAND JOURNAL OF MEDICINE (2012)
Rapamycin Ameliorates Kidney Fibrosis by Inhibiting the Activation of mTOR Signaling in Interstitial Macrophages and Myofibroblasts
Guochun Chen et al.
PLOS ONE (2012)
Everolimus-based, calcineurin-inhibitor-free regimen in recipients of de-novo kidney transplants: an open-label, randomised, controlled trial
Klemens Budde et al.
LANCET (2011)
The potential benefits of rapamycin on renal function, tolerance, fibrosis, and malignancy following transplantation
Edward K. Geissler et al.
KIDNEY INTERNATIONAL (2010)
Efficacy and safety of de novo or early everolimus with low cyclosporine in deceased-donor kidney transplant recipients at specified risk of delayed graft function: 12-month results of a randomized, multicenter trial
Jacques Dantal et al.
TRANSPLANT INTERNATIONAL (2010)
Efficacy on Renal Function of Early Conversion from Cyclosporine to Sirolimus 3 Months After Renal Transplantation: Concept Study
Y. Lebranchu et al.
AMERICAN JOURNAL OF TRANSPLANTATION (2009)
Increased AKT S473 phosphorylation after mTORC1 inhibition is rictor dependent and does not predict tumor cell response to PI3K/mTOR inhibition
Madlaina Breuleux et al.
MOLECULAR CANCER THERAPEUTICS (2009)
Practical recommendations for the early use of m-TOR inhibitors (sirolimus) in renal transplantation
Josep M. Campistol et al.
TRANSPLANT INTERNATIONAL (2009)
Conversion From Calcineurin Inhibitors to Sirolimus Maintenance Therapy in Renal Allograft Recipients: 24-Month Efficacy and Safety Results From the CONVERT Trial
Francesco P. Schena et al.
TRANSPLANTATION (2009)
Early, abrupt conversion of de novo renal transplant patients from cyclosporine to everolimus:: results of a pilot study
H. Holdaas et al.
CLINICAL TRANSPLANTATION (2008)
Impact of cold ischemia time on renal allograft outcome using kidneys from young donors
Domingo Hernandez et al.
TRANSPLANT INTERNATIONAL (2008)
Rapamycin inhibits PAI-1 expression and reduces interstitial fibrosis and glomerulosclerosis in chronic allograft nephropathy
Paola Pontrelli et al.
TRANSPLANTATION (2008)
Ischemia/Reperfusion Injury in Kidney Transplantation: Mechanisms and Prevention
M. Kosieradzki et al.
TRANSPLANTATION PROCEEDINGS (2008)
Influence of hypersulfated and low molecular weight heparins on ischemia/reperfusion: injury and allograft rejection in rat kidneys
Uwe Gottmann et al.
TRANSPLANT INTERNATIONAL (2007)
Rapamycin induces feedback activation of Akt signaling through an IGF-1R-dependent mechanism
X. Wan et al.
ONCOGENE (2007)
Multicenter analysis of kidney preservation
Gerhard Opelz et al.
TRANSPLANTATION (2007)
Common and unique mechanisms regulate fibrosis in various fibroproliferative diseases
Thomas A. Wynn
JOURNAL OF CLINICAL INVESTIGATION (2007)
Risk factors for early epithelial to mesenchymal transition in renal grafts
A. Hertig et al.
AMERICAN JOURNAL OF TRANSPLANTATION (2006)
Cardiovascular complications after renal transplantation and their prevention
Akinlolu O. Ojo
TRANSPLANTATION (2006)
Immunosuppression: Evolution in practice and trends, 1994-2004
HU Meier-Kriesche et al.
AMERICAN JOURNAL OF TRANSPLANTATION (2006)
Update on mechanisms of ischemic acute kidney injury
Prasad Devarajan
JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY (2006)
Chronic renal allograft dysfunction
JR Chapman et al.
JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY (2005)
Epithelial to mesenchymal transition during late deterioration of human kidney transplants: The role of tubular cells in fibrogenesis
A Vongwiwatana et al.
AMERICAN JOURNAL OF TRANSPLANTATION (2005)
Lack of improvement in renal allograft survival despite a marked decrease in acute rejection rates over the most recent era
HU Meier-Kriesche et al.
AMERICAN JOURNAL OF TRANSPLANTATION (2004)
Transdifferentiation of cultured tubular cells induced by hypoxia
K Manotham et al.
KIDNEY INTERNATIONAL (2004)
Cold ischemia and the reduced long-term survival of cadaveric renal allografts
AK Salahudeen et al.
KIDNEY INTERNATIONAL (2004)
Delayed graft function in kidney transplantation
N Perico et al.
LANCET (2004)
Effect of N-desulfated heparin on hepatic/renal ischemia reperfusion injury in rats
T Zhou et al.
WORLD JOURNAL OF GASTROENTEROLOGY (2002)
A calcineurin antagonist-free induction strategy for immunosuppression in cadaveric kidney transplant recipients at risk for delayed graft function
JC Hong et al.
TRANSPLANTATION (2001)
Share Paper
